Replies to post #224062 on Biotech Values

[jbog]

I always suspected ABT was cashing in on Humira when the price was right. Abbv will be a totally different company once it loses the gravy train.

[Rocky3]

ABT has now performed considerably better than ABBV since the corporate split on 1/1/13.

Love to see your math on that. You are surely right that ABBV is closer than it has been in the last 6 years, but on any total-return basis that I have looked at, it is not even close. What am I missing?